Trina Solar Update & More!

[david phillips]

With many positives developing for solar companies and the industry,
such as subsidies offered by governments and plummeting prices of the
key raw material poly-silicon, why are the solar stocks giving up
their huge gains of the last three months? Could it be that “grid
parity” is more dependent on the price of fossil fuels than previously
hypothesized? Just check out the fortunes at solar panel maker Trina
Solar (TSL-$26.00) for answers … Read More at BNET Energy:

http://industry.bnet.com/energy/10001968/trina-solar-still-struggling-to-bring-manufacturing-costs-in-line-with-falling-prices/

Given Blockbuster’s (BBI-$1.17) existing debt-service obligations on
its levered capital structure, I remain skeptical that the motivation
behind the new purchase arrangements was not for growth, but an
attempt by the video retail chain to continue managing the business
for cash conservation, as additional credit restrictions were forced
on the company by its suppliers… Continue Reading at BNET Retail:

http://industry.bnet.com/retail/10003729/conserving-cash-is-blockbusters-winning-initiative/?tag=content;set-more-posts

Even if Optimer Pharma (OPTR-$12.82) obtains regulatory approval to
market its antibiotic fidaxomicin, its commercial success will be
limited, as the FDA is likely to move forward on an advisory
committee’s recommendation for the sale of cheaper copies of generic
Vancocin… Read Details at BNET Pharma:

http://industry.bnet.com/pharma/10003960/generic-threat-to-optimer-pharmas-fidaxomicin-antibiotic/